[The effect of progestins on endometrial cancer in morphometric evaluation]. 2001

K Rozdolski
II Katedry i Kliniki Ginekologii Akademii Medycznej we Wrocławiu.

The morphometric estimation of the influence of the caproate 17-alfa-hydroxyprogesterone on the endometrial cancer was the aim this work. The quantitative evaluation of the reaction of neoplasmatic and some stromal cells such as fibroblast, fibrocytes, lymphocytes, macrophages was carried out. Every patient was given a high doses of the medicine before the operation. The comparison of the histological image and than morphometric estimation was done after operation. Examination was performed in three separate groups depending on the grading of the tumor. The result was the decreased number of the neoplasmatic cells in every group independently on the grading. In the fibroblasts and fibrocytes groups the increased number of cells especially in the G1 and G2 group was observed. In the group of lymphocytes and macrophages the increased number of all cells was observed in every group. On the basic of our results we assume that the application of the high doses of progestins decreased number of neoplasmatic cells and stimulates the cells of the monocyte-macrophage system.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006908 Hydroxyprogesterones Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
D000077713 17 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS. 17 alpha-Oxyprogesterone Capronate,17-Hydroxyprogesterone Capronate,17-alpha-Hydroxy-Progesterone Caproate,Delalutin,Hydroxyprogesterone Caproate,Hydroxyprogesterone Hexanoate,Makena,Neolutin,Oxyprogesterone Caproate,Prolutin Depot,Proluton Depot,17 Hydroxyprogesterone Capronate,17 alpha Hydroxy Progesterone Caproate,17 alpha Hydroxyprogesterone Caproate,17 alpha Oxyprogesterone Capronate,Caproate, 17-alpha-Hydroxy-Progesterone
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

K Rozdolski
December 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
K Rozdolski
March 1985, Revue francaise de gynecologie et d'obstetrique,
K Rozdolski
January 1990, Sovetskaia meditsina,
K Rozdolski
December 1986, Clinics in obstetrics and gynaecology,
K Rozdolski
January 2008, Indian journal of pathology & microbiology,
Copied contents to your clipboard!